Glaxosmithkline | GSK - Dywidenda Wydajność





Dy Zmiana Data
AbbVie 3.1 0.19 2026-03
Amgen 2.78 0.17 2026-03
AstraZeneca USD 1.18 0.56 2026-03
Bristol-Myers Squibb 4.12 3.9 2026-03
Drreddys Laboratories INR 0.66 0.01 2026-03
Eli Lilly 0.58 0.16 2025-12
GlaxoSmithKline 0.82 3.75 2026-03
Glaxosmithkline GBP 4.47 0.32 2025-12
J&J 2.16 0.34 2026-03
Merck 2.76 0.36 2026-03
Novartis USD 3.33 0.29 2026-03
Perrigo 12.17 3.84 2026-03
Pfizer 6.36 0.55 2026-03
Phibro Animal Health 1.28 0.1 2025-12
Roche Holding 2.96 0.8 2025-12
Sanofi 4.98 0.24 2026-03
Takeda 1.65 2.43 2026-03
Zoetis 1.74 0.13 2026-03